Last reviewed · How we verify
NCT06707714: Metabolomics
A Metabolomics-based Study to Explore the Mechanism of Remission of Metabolic Syndrome After Radical Gastrectomy
trial testing hypertension in Metabolic Syndrome in 150 participants. Enrolling by invitation.
1 July 2026
Quick facts
| Lead sponsor | Dong Peng |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 1 July 2023 |
| Primary completion | 1 July 2026 |
| Estimated completion | 1 July 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- hypertension — full drug profile →
- diabetes
- fatty liver
Conditions studied
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
- Gastric Cancer — all drugs for Gastric Cancer →
Sponsor
Dong Peng
Who can join
18 and older, any sex, with Metabolic Syndrome or Gastric Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
1. Analysis of preoperative and postoperative metabolite changes: Through metabolomics technology, the changes of preoperative and postoperative metabolites in patients with gastric cancer complicated with metabolic syndrome were systematically analyzed, and the key metabolites related to the remission of hypertension, hyperlipidemia, and diabetes after surgery were found. 2. Explore the influencing factors of postoperative remission of metabolic syndrome: Combined with clinical data, the association between various metabolites and the degree of postoperative remission was evaluated, and the main factors affecting postoperative remission were determined. 3. Reveal the mechanism of postoperative remission of metabolic syndrome: through multi-level metabolomics analysis, to clarify the metabolic pathways and mechanisms involved in the process of postoperative remission, and provide a new theoretical basis for the development of tumor metabolic surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06707714
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of hypertension
Trials testing the same drug.
- NCT06645730 — Metabolomics Predictors for Metabolic Disease Remission After Metabolic Syndrome Surgery. · active not recruiting
- NCT04433416 — Hypertension and Controlled Hypotension in the Elderly · completed
Other recruiting trials for Metabolic Syndrome
Currently open trials in the same condition.
- NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
- NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
- NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting
Other Dong Peng trials
Trials by the same sponsor.
- NCT07126743 — Organic Pollutant Build-Up in Body Fat and Stomach Tissue Linked to Obesity Levels · active not recruiting
- NCT07063550 — Microplastics in Paraneoplastic and Intratumoral for Colorectal Cancer · active not recruiting
- NCT06856382 — The Association Between Microplastics and Macrogenomics and Metabolomics in Gastric Cancer · active not recruiting
- NCT06854146 — The Effect of Environmental Factors on Gastric Cancer Based on Macrogenome · active not recruiting
- NCT06852495 — the Effect of Environmental Factors on Colorectal Cancer Based on Macrogenomes · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06707714 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dong Peng
- Last refreshed: 27 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06707714.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing